Ejtahed Hanieh-Sadat, Hoseini-Tavassol Zahra, Khatami Shohre, Zangeneh Mehrangiz, Behrouzi Ava, Ahmadi Badi Sara, Moshiri Arfa, Hasani-Ranjbar Shirin, Soroush Ahmad-Reza, Vaziri Farzam, Fateh Abolfazl, Ghanei Mostafa, Bouzari Saeid, Najar-Peerayeh Shahin, Siadat Seyed Davar, Larijani Bagher
Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Diabetes Metab Disord. 2020 Feb 8;19(1):265-271. doi: 10.1007/s40200-020-00502-7. eCollection 2020 Jun.
Regarding the role of gut microbial dysbiosis in hyperglycemia, we aimed to compare the main gut bacterial composition among type 1 and type 2 diabetic patients and healthy non-diabetic adults.
A total of 110 adult subjects (49 patients diagnosed with type 2 diabetes, 21 patients diagnosed with type 1 diabetes and 40 healthy persons) were included in this case-control study. The intestinal microbiota composition was investigated by quantitative real-time polymerase chain reaction (qPCR) method targeting bacterial 16S rRNA gene. Comparison between three groups was done using one-way analysis of variance.
The participants' mean age in the type 1 diabetes, type 2 diabetes and control groups was 35.4, 57.2 and 38.0 years, respectively. Higher level of , and was observed in both type 1 and type 2 diabetic patients compared with the healthy group (P ˂0.001). In contrast, bacterial load of , and was higher in healthy control group ( < 0.05). was significantly lower in type 1 diabetic patients compared with the other two groups (P ˂0.001). No significant difference was found in level among three groups.
Gut microbial alterations have been observed among patients suffering from type 1 and type 2 diabetes mellitus and healthy control adults. Butyrate producing genera including and decreased while , and increased in diabetic patients compared to healthy subjects. Modulating approaches of gut microbiota composition could be helpful in diabetes management.
关于肠道微生物群失调在高血糖中的作用,我们旨在比较1型和2型糖尿病患者与健康非糖尿病成年人的主要肠道细菌组成。
本病例对照研究共纳入110名成年受试者(49例2型糖尿病患者、21例1型糖尿病患者和40名健康人)。采用针对细菌16S rRNA基因的定量实时聚合酶链反应(qPCR)方法研究肠道微生物群组成。三组之间的比较采用单因素方差分析。
1型糖尿病组、2型糖尿病组和对照组参与者的平均年龄分别为35.4岁、57.2岁和38.0岁。与健康组相比,1型和2型糖尿病患者的 、 和 水平均较高(P<0.001)。相反,健康对照组的 、 和 细菌载量较高( <0.05)。1型糖尿病患者的 明显低于其他两组(P<0.001)。三组之间的 水平无显著差异。
在1型和2型糖尿病患者以及健康对照成年人中均观察到肠道微生物改变。与健康受试者相比,糖尿病患者中包括 和 在内的产丁酸盐菌属减少,而 、 和 增加。调节肠道微生物群组成的方法可能有助于糖尿病的管理。